We've found
10,106 Gastrointestinal
clinical trials
We've found
10,106 Gastrointestinal
clinical trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

NAFLD - Nonalcoholic Fatty Liver Disease Clinical Trial
Updated: 12/31/1969
Losartan for the Treatment of Pediatric NAFLD
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Diabetic Foot Ulcer Recurrence: Pilot Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatic Impairment Clinical Trial
Updated: 12/31/1969
Tepotinib Hepatic Impairment Trial
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology, Other Clinical Trial
Updated: 12/31/1969
Vitamin D for Muscle Metabolic Function in Cancer Cachexia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Sclerosing Cholangitis Clinical Trial
Updated: 12/31/1969
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cirrhosis Clinical Trial
Updated: 12/31/1969
Health IT Generated PROs to Improve Outcomes in Cirrhosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Lymphoblastic Leukemia Clinical Trial
Updated: 12/31/1969
Treatment of Hyperbilirubinemia Due to PEG-asparaginase and Inotuzumab Ozogamicin in Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Musculoskeletal, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Efficacy of Audio Recorded Guided Imagery vs Deep Breathing Exercises on Functional Gastrointestinal Pain Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Short or Long Interval to Ileostomy Reversal After Ileal Pouch Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Short or Long Interval to Ileostomy Reversal After Ileal Pouch Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Short or Long Interval to Ileostomy Reversal After Ileal Pouch Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Other Clinical Trial
Updated: 12/31/1969
Repeated-dose Safety, Efficacy, PK and PD of CTAP101, IR Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With SHPT, CKD 3-4 and VDI
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
2-Week Study In People With Nonalcoholic Fatty Liver Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Barrett's Esophagus With Dysplasia Clinical Trial
Updated: 12/31/1969
Characterization of the Neo-squamous Epithelial Barrier
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
Updated: 12/31/1969
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Prospective Observational Study of TPIAT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Prospective Observational Study of TPIAT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Prospective Observational Study of TPIAT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Prospective Observational Study of TPIAT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Prospective Observational Study of TPIAT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Helicobacter Pylori Genome Project
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Other Clinical Trial
Updated: 12/31/1969
Liver, Pancreas and Thyroid Function in Burn Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
